FDA May Take Action Against Johnson & Johnson
Posted on June 1st, 2010 by Oddo & Babat, P.C.
The New York Times (5/28, B1, Singer) reports that McNeil Consumer Healthcare, the division of Johnson & Johnson that recalled millions of bottles of liquid children’s Tylenol, “may face criminal penalties, product seizures, or other sanctions, an official from the Food and Drug Administration said Thursday.” At a Congressional hearing yesterday, the principal deputy commissioner […]
Senate Committee Links Diabetes Drug Avandia to Heart Attacks, Death
Posted on February 24th, 2010 by Oddo & Babat, P.C.
On February 20, 2010 the New York Times carried a front-page story reporting that hundreds of patients taking the controversial diabetes medicine, Avandia (rosiglitazone), needlessly suffered heart attacks and heart failure each month, according to confidential governmental reports. The Wall Street Journal (Monday, 2/22), reported that a Senate Finance Committee concluded that Glaxo was aware […]